These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 33015007)

  • 1. Corrigendum: Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System.
    Xu R; Shi M; Li J; Song P; Li N
    Front Bioeng Biotechnol; 2020; 8():1026. PubMed ID: 33015007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System.
    Xu R; Shi M; Li J; Song P; Li N
    Front Bioeng Biotechnol; 2020; 8():862. PubMed ID: 32850726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper.
    Belenkaya SV; Merkuleva IA; Yarovaya OI; Chirkova VY; Sharlaeva EA; Shanshin DV; Volosnikova EA; Vatsadze SZ; Khvostov MV; Salakhutdinov NF; Shcherbakov D
    Front Bioeng Biotechnol; 2023; 11():1294266. PubMed ID: 38026885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID.
    Goh D; Lim JCT; Fernaíndez SB; Joseph CR; Edwards SG; Neo ZW; Lee JN; Caballero SG; Lau MC; Yeong JPS
    Front Immunol; 2022; 13():1036894. PubMed ID: 36275692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corrigendum to "PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2"[Heliyon 7 (10) (October 2021) e08124].
    Mazumder S; Rastogi R; Undale A; Arora K; Arora NM; Pratim B; Kumar D; Joseph A; Mali B; Arya VB; Kalyanaraman S; Mukherjee A; Gupta A; Potdar S; Roy SS; Parashar D; Paliwal J; Singh SK; Naqvi A; Srivastava A; Singh MK; Kumar D; Bansal S; Rautray S; Saini M; Jain K; Gupta R; Kundu PK
    Heliyon; 2021 Oct; 7(10):e08201. PubMed ID: 34697601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum: An Alternative Perfusion Approach for the Intensification of Virus-Like Particle Production in HEK293 Cultures.
    Lavado-García J; Cervera L; Gòdia F
    Front Bioeng Biotechnol; 2021; 9():708773. PubMed ID: 34692651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Protecting Healthcare Workers Amid the COVID-19 Crisis: A Safety Protocol in Wuhan.
    Liu Y; Yang S; Hung M; Tong W; Liu Y
    Front Public Health; 2021; 9():660323. PubMed ID: 33763403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Impact of SARS-CoV-2 Infection During Pregnancy on Infant Neurobehavioral Development: A Case-Control Study.
    Cheng Y; Teng H; Xiao Y; Yao M; Yin J; Sun G
    Front Pediatr; 2022; 10():853389. PubMed ID: 35359898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Virus-like particles are efficient tools for boosting mRNA-induced antibodies.
    Frontiers Production Office
    Front Immunol; 2023; 14():1183189. PubMed ID: 37025996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: Development and Delivery Systems of mRNA Vaccines.
    Liang Y; Huang L; Liu T
    Front Bioeng Biotechnol; 2021; 9():766764. PubMed ID: 34604193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: Do Humidity and Temperature Impact the Spread of the Novel Coronavirus?
    Yuan S; Jiang SC; Li ZL
    Front Public Health; 2020; 8():317. PubMed ID: 32719763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: Targeting Endolysosomal Two-Pore Channels to Treat Cardiovascular Disorders in the Novel COronaVIrus Disease 2019.
    Moccia F; Negri S; Faris P; Perna A; De Luca A; Soda T; Berra-Romani R; Guerra G
    Front Physiol; 2021; 12():690189. PubMed ID: 34122151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review.
    Yang ZH; Wang B; Ma Q; Wang L; Lin YX; Yan HF; Fan ZX; Chen HJ; Ge Z; Zhu F; Wang HJ; Zhang BN; Sun HD; Feng LM
    Front Pharmacol; 2021; 12():770125. PubMed ID: 34759829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Aerosol test chambers: Current state and practice during the COVID-19 pandemic.
    Yeh KB; Setser B
    Front Bioeng Biotechnol; 2022; 10():1036662. PubMed ID: 36338111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Immune and Clinical Features of
    Zhang Q; Zhong H; Fan Y; Liu Q; Song J; Yao S; Cao F
    Front Bioeng Biotechnol; 2020; 8():599544. PubMed ID: 33195173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Identification of novel therapeutic candidates against SARS-CoV-2 infections: An application of RNA sequencing toward mRNA based nanotherapeutics.
    Khalid Z; Huan M; Sohail Raza M; Abbas M; Naz Z; Kombe Kombe AJ; Zeng W; He H; Jin T
    Front Microbiol; 2022; 13():1059437. PubMed ID: 36338104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: Coronavirus Disease-2019 Survival in Mexico: A Cohort Study on the Interaction of the Associated Factors.
    Márquez-González H; Méndez-Galván JF; Reyes-López A; Klünder-Klünder M; Jiménez-Juárez R; Garduño-Espinosa J; Solórzano-Santos F
    Front Public Health; 2021; 9():754703. PubMed ID: 34660524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Diagnostic Delay of Pulmonary Embolism in COVID-19 Patients.
    Melazzini F; Reduzzi M; Quaglini S; Fumoso F; Lenti MV; Di Sabatino A
    Front Med (Lausanne); 2022; 9():884680. PubMed ID: 35402449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Impact of COVID-19 in-hospital mortality in chagas disease patients.
    Sperandio da Silva GM; Mediano MFF; Murgel MF; Andrade PM; de Holanda MT; da Costa AR; Veloso HH; Carneiro FM; Valete Rosalino CM; de Sousa AS; Mendes FSNS; Pinheiro RO; Veloso VG; Saraiva RM; Hasslocher-Moreno AM
    Front Med (Lausanne); 2022; 9():963805. PubMed ID: 35957851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story.
    Bisceglia I; Canale ML; Gallucci G; Turazza FM; Lestuzzi C; Parrini I; Russo G; Maurea N; Quagliariello V; Oliva S; Di Fusco SA; Lucà F; Tarantini L; Trambaiolo P; Moreo A; Geraci G; Gabrielli D; Gulizia MM; Oliva F; Colivicchi F
    Front Cardiovasc Med; 2022; 9():903766. PubMed ID: 35647054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.